Advertisement

Index by author

June 01, 1992; Volume 41,Issue 6

A

  1. Audigier, Y

    1. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
      A Varrault, L Journot, Y Audigier and J Bockaert
      Molecular Pharmacology June 1992, 41 (6) 999-1007;

B

  1. Bachur, N R

    1. Helicase inhibition by anthracycline anticancer agents.
      N R Bachur, F Yu, R Johnson, R Hickey, Y Wu and L Malkas
      Molecular Pharmacology June 1992, 41 (6) 993-998;

  2. Barber, D L

    1. Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange.
      D L Barber, M B Ganz, P B Bongiorno and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1056-1060;

  3. Barden, N

    1. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment.
      M C Pepin, M V Govindan and N Barden
      Molecular Pharmacology June 1992, 41 (6) 1016-1022;

  4. Bennett, C F

    1. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
      C F Bennett, M Y Chiang, H Chan, J E Shoemaker and C K Mirabelli
      Molecular Pharmacology June 1992, 41 (6) 1023-1033;

  5. Ber, E

    1. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
      M A Cascieri, R R Huang, T M Fong, A H Cheung, S Sadowski, E Ber and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1096-1099;

  6. Bergeron, F

    1. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
      C Durieux, M Ruiz-Gayo, P J Corringer, F Bergeron, B Ducos and B P Roques
      Molecular Pharmacology June 1992, 41 (6) 1089-1095;

  7. Bockaert, J

    1. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
      A Varrault, L Journot, Y Audigier and J Bockaert
      Molecular Pharmacology June 1992, 41 (6) 999-1007;

  8. Bongiorno, P B

    1. Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange.
      D L Barber, M B Ganz, P B Bongiorno and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1056-1060;

C

  1. Carver, G T

    1. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization.
      L H Overby, S Nishio, A Weir, G T Carver, C G Plopper and R M Philpot
      Molecular Pharmacology June 1992, 41 (6) 1039-1046;

  2. Cascieri, M A

    1. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
      M A Cascieri, R R Huang, T M Fong, A H Cheung, S Sadowski, E Ber and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1096-1099;

  3. Chambers, T C

    1. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
      T C Chambers, B Zheng and J F Kuo
      Molecular Pharmacology June 1992, 41 (6) 1008-1015;

  4. Chan, H

    1. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
      C F Bennett, M Y Chiang, H Chan, J E Shoemaker and C K Mirabelli
      Molecular Pharmacology June 1992, 41 (6) 1023-1033;

  5. Changeux, J P

    1. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
      B Chatrenet, F Kotzba-Hibert, C Mulle, J P Changeux, M P Goeldner and C Hirth
      Molecular Pharmacology June 1992, 41 (6) 1100-1106;

  6. Chatrenet, B

    1. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
      B Chatrenet, F Kotzba-Hibert, C Mulle, J P Changeux, M P Goeldner and C Hirth
      Molecular Pharmacology June 1992, 41 (6) 1100-1106;

  7. Cheung, A H

    1. Involvement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the beta-adrenergic receptor in the activation of Gs.
      A H Cheung, R R Huang and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1061-1065;
    2. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
      M A Cascieri, R R Huang, T M Fong, A H Cheung, S Sadowski, E Ber and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1096-1099;

  8. Chiang, M Y

    1. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
      C F Bennett, M Y Chiang, H Chan, J E Shoemaker and C K Mirabelli
      Molecular Pharmacology June 1992, 41 (6) 1023-1033;

  9. Corringer, P J

    1. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
      C Durieux, M Ruiz-Gayo, P J Corringer, F Bergeron, B Ducos and B P Roques
      Molecular Pharmacology June 1992, 41 (6) 1089-1095;

  10. Crane, M R

    1. Identification of two affinity states of low affinity receptors for Escherichia coli heat-stable enterotoxin: correlation of occupation of lower affinity state with guanylate cyclase activation.
      M R Crane, M Hugues, P D O'Hanley and S A Waldman
      Molecular Pharmacology June 1992, 41 (6) 1073-1080;

D

  1. Daujat, M

    1. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes.
      L Pichard, I Fabre, M Daujat, J Domergue, H Joyeux and P Maurel
      Molecular Pharmacology June 1992, 41 (6) 1047-1055;

  2. Domergue, J

    1. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes.
      L Pichard, I Fabre, M Daujat, J Domergue, H Joyeux and P Maurel
      Molecular Pharmacology June 1992, 41 (6) 1047-1055;

  3. Ducos, B

    1. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
      C Durieux, M Ruiz-Gayo, P J Corringer, F Bergeron, B Ducos and B P Roques
      Molecular Pharmacology June 1992, 41 (6) 1089-1095;

  4. Durieux, C

    1. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
      C Durieux, M Ruiz-Gayo, P J Corringer, F Bergeron, B Ducos and B P Roques
      Molecular Pharmacology June 1992, 41 (6) 1089-1095;

E

  1. Edgar, P P

    1. Functionally relevant gamma-aminobutyric acidA receptors: equivalence between receptor affinity (Kd) and potency (EC50)?
      P P Edgar and R D Schwartz
      Molecular Pharmacology June 1992, 41 (6) 1124-1129;

  2. Entzeroth, M

    1. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
      W Wienen, A B Mauz, J C Van Meel and M Entzeroth
      Molecular Pharmacology June 1992, 41 (6) 1081-1088;

F

  1. Fabre, I

    1. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes.
      L Pichard, I Fabre, M Daujat, J Domergue, H Joyeux and P Maurel
      Molecular Pharmacology June 1992, 41 (6) 1047-1055;

  2. Farber, J L

    1. Effects of vitamin E on the killing of cultured hepatocytes by tert-butyl hydroperoxide.
      P A Glascott, E Gilfor and J L Farber
      Molecular Pharmacology June 1992, 41 (6) 1155-1162;

  3. Fong, T M

    1. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
      M A Cascieri, R R Huang, T M Fong, A H Cheung, S Sadowski, E Ber and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1096-1099;

  4. Förstermann, U

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

G

  1. Ganz, M B

    1. Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange.
      D L Barber, M B Ganz, P B Bongiorno and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1056-1060;

  2. Gilfor, E

    1. Effects of vitamin E on the killing of cultured hepatocytes by tert-butyl hydroperoxide.
      P A Glascott, E Gilfor and J L Farber
      Molecular Pharmacology June 1992, 41 (6) 1155-1162;

  3. Glascott, P A

    1. Effects of vitamin E on the killing of cultured hepatocytes by tert-butyl hydroperoxide.
      P A Glascott, E Gilfor and J L Farber
      Molecular Pharmacology June 1992, 41 (6) 1155-1162;

  4. Goeldner, M P

    1. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
      B Chatrenet, F Kotzba-Hibert, C Mulle, J P Changeux, M P Goeldner and C Hirth
      Molecular Pharmacology June 1992, 41 (6) 1100-1106;

  5. Govindan, M V

    1. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment.
      M C Pepin, M V Govindan and N Barden
      Molecular Pharmacology June 1992, 41 (6) 1016-1022;

H

  1. Hagiwara, M

    1. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
      S Wakusawa, S Nakamura, K Tajima, K Miyamoto, M Hagiwara and H Hidaka
      Molecular Pharmacology June 1992, 41 (6) 1034-1038;

  2. Hahner, L D

    1. Activation of protein kinase C selectively inhibits the gamma-aminobutyric acidA receptor: role of desensitization.
      N J Leidenheimer, S J McQuilkin, L D Hahner, P Whiting and R A Harris
      Molecular Pharmacology June 1992, 41 (6) 1116-1123;

  3. Harris, R A

    1. Activation of protein kinase C selectively inhibits the gamma-aminobutyric acidA receptor: role of desensitization.
      N J Leidenheimer, S J McQuilkin, L D Hahner, P Whiting and R A Harris
      Molecular Pharmacology June 1992, 41 (6) 1116-1123;

  4. Hickey, R

    1. Helicase inhibition by anthracycline anticancer agents.
      N R Bachur, F Yu, R Johnson, R Hickey, Y Wu and L Malkas
      Molecular Pharmacology June 1992, 41 (6) 993-998;

  5. Hidaka, H

    1. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
      S Wakusawa, S Nakamura, K Tajima, K Miyamoto, M Hagiwara and H Hidaka
      Molecular Pharmacology June 1992, 41 (6) 1034-1038;

  6. Hirth, C

    1. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
      B Chatrenet, F Kotzba-Hibert, C Mulle, J P Changeux, M P Goeldner and C Hirth
      Molecular Pharmacology June 1992, 41 (6) 1100-1106;

  7. Hoffman, P L

    1. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function.
      K R Iorio, L Reinlib, B Tabakoff and P L Hoffman
      Molecular Pharmacology June 1992, 41 (6) 1142-1148;

  8. Huang, R R

    1. Involvement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the beta-adrenergic receptor in the activation of Gs.
      A H Cheung, R R Huang and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1061-1065;
    2. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
      M A Cascieri, R R Huang, T M Fong, A H Cheung, S Sadowski, E Ber and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1096-1099;

  9. Huettner, J E

    1. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
      K J Swartz, W J Koroshetz, A H Rees and J E Huettner
      Molecular Pharmacology June 1992, 41 (6) 1130-1141;

  10. Hugues, M

    1. Identification of two affinity states of low affinity receptors for Escherichia coli heat-stable enterotoxin: correlation of occupation of lower affinity state with guanylate cyclase activation.
      M R Crane, M Hugues, P D O'Hanley and S A Waldman
      Molecular Pharmacology June 1992, 41 (6) 1073-1080;

I

  1. Iben, L

    1. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
      F D Yocca, L Iben and E Meller
      Molecular Pharmacology June 1992, 41 (6) 1066-1072;

  2. Iorio, K R

    1. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function.
      K R Iorio, L Reinlib, B Tabakoff and P L Hoffman
      Molecular Pharmacology June 1992, 41 (6) 1142-1148;

J

  1. Johnson, R

    1. Helicase inhibition by anthracycline anticancer agents.
      N R Bachur, F Yu, R Johnson, R Hickey, Y Wu and L Malkas
      Molecular Pharmacology June 1992, 41 (6) 993-998;

  2. Journot, L

    1. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
      A Varrault, L Journot, Y Audigier and J Bockaert
      Molecular Pharmacology June 1992, 41 (6) 999-1007;

  3. Joyeux, H

    1. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes.
      L Pichard, I Fabre, M Daujat, J Domergue, H Joyeux and P Maurel
      Molecular Pharmacology June 1992, 41 (6) 1047-1055;

K

  1. Kohlhaas, K L

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

  2. Koroshetz, W J

    1. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
      K J Swartz, W J Koroshetz, A H Rees and J E Huettner
      Molecular Pharmacology June 1992, 41 (6) 1130-1141;

  3. Kotzba-Hibert, F

    1. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
      B Chatrenet, F Kotzba-Hibert, C Mulle, J P Changeux, M P Goeldner and C Hirth
      Molecular Pharmacology June 1992, 41 (6) 1100-1106;

  4. Kuo, J F

    1. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
      T C Chambers, B Zheng and J F Kuo
      Molecular Pharmacology June 1992, 41 (6) 1008-1015;

L

  1. Leidenheimer, N J

    1. Activation of protein kinase C selectively inhibits the gamma-aminobutyric acidA receptor: role of desensitization.
      N J Leidenheimer, S J McQuilkin, L D Hahner, P Whiting and R A Harris
      Molecular Pharmacology June 1992, 41 (6) 1116-1123;

M

  1. Malkas, L

    1. Helicase inhibition by anthracycline anticancer agents.
      N R Bachur, F Yu, R Johnson, R Hickey, Y Wu and L Malkas
      Molecular Pharmacology June 1992, 41 (6) 993-998;

  2. Matsumoto, T

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

  3. Maurel, P

    1. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes.
      L Pichard, I Fabre, M Daujat, J Domergue, H Joyeux and P Maurel
      Molecular Pharmacology June 1992, 41 (6) 1047-1055;

  4. Mauz, A B

    1. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
      W Wienen, A B Mauz, J C Van Meel and M Entzeroth
      Molecular Pharmacology June 1992, 41 (6) 1081-1088;

  5. McQuilkin, S J

    1. Activation of protein kinase C selectively inhibits the gamma-aminobutyric acidA receptor: role of desensitization.
      N J Leidenheimer, S J McQuilkin, L D Hahner, P Whiting and R A Harris
      Molecular Pharmacology June 1992, 41 (6) 1116-1123;

  6. Meller, E

    1. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
      F D Yocca, L Iben and E Meller
      Molecular Pharmacology June 1992, 41 (6) 1066-1072;

  7. Miledi, R

    1. Effects of hexachlorocyclohexanes on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by RNA from mammalian brain and retina.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology June 1992, 41 (6) 1107-1115;

  8. Mirabelli, C K

    1. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
      C F Bennett, M Y Chiang, H Chan, J E Shoemaker and C K Mirabelli
      Molecular Pharmacology June 1992, 41 (6) 1023-1033;

  9. Mitchell, J A

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

  10. Miyamoto, K

    1. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
      S Wakusawa, S Nakamura, K Tajima, K Miyamoto, M Hagiwara and H Hidaka
      Molecular Pharmacology June 1992, 41 (6) 1034-1038;

  11. Mulle, C

    1. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
      B Chatrenet, F Kotzba-Hibert, C Mulle, J P Changeux, M P Goeldner and C Hirth
      Molecular Pharmacology June 1992, 41 (6) 1100-1106;

  12. Murad, F

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

N

  1. Nakamura, S

    1. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
      S Wakusawa, S Nakamura, K Tajima, K Miyamoto, M Hagiwara and H Hidaka
      Molecular Pharmacology June 1992, 41 (6) 1034-1038;

  2. Nishio, S

    1. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization.
      L H Overby, S Nishio, A Weir, G T Carver, C G Plopper and R M Philpot
      Molecular Pharmacology June 1992, 41 (6) 1039-1046;

O

  1. O'Hanley, P D

    1. Identification of two affinity states of low affinity receptors for Escherichia coli heat-stable enterotoxin: correlation of occupation of lower affinity state with guanylate cyclase activation.
      M R Crane, M Hugues, P D O'Hanley and S A Waldman
      Molecular Pharmacology June 1992, 41 (6) 1073-1080;

  2. Overby, L H

    1. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization.
      L H Overby, S Nishio, A Weir, G T Carver, C G Plopper and R M Philpot
      Molecular Pharmacology June 1992, 41 (6) 1039-1046;

P

  1. Pepin, M C

    1. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment.
      M C Pepin, M V Govindan and N Barden
      Molecular Pharmacology June 1992, 41 (6) 1016-1022;

  2. Philpot, R M

    1. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization.
      L H Overby, S Nishio, A Weir, G T Carver, C G Plopper and R M Philpot
      Molecular Pharmacology June 1992, 41 (6) 1039-1046;

  3. Pichard, L

    1. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes.
      L Pichard, I Fabre, M Daujat, J Domergue, H Joyeux and P Maurel
      Molecular Pharmacology June 1992, 41 (6) 1047-1055;

  4. Plopper, C G

    1. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization.
      L H Overby, S Nishio, A Weir, G T Carver, C G Plopper and R M Philpot
      Molecular Pharmacology June 1992, 41 (6) 1039-1046;

  5. Polenzani, L

    1. Effects of hexachlorocyclohexanes on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by RNA from mammalian brain and retina.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology June 1992, 41 (6) 1107-1115;

  6. Pollock, J S

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

Q

  1. Qu, W

    1. Stimulation of monooxygenation and conjugation after liver transplantation in the rat: involvement of Kupffer cells.
      W Qu, E Savier and R G Thurman
      Molecular Pharmacology June 1992, 41 (6) 1149-1154;

R

  1. Rees, A H

    1. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
      K J Swartz, W J Koroshetz, A H Rees and J E Huettner
      Molecular Pharmacology June 1992, 41 (6) 1130-1141;

  2. Reinlib, L

    1. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function.
      K R Iorio, L Reinlib, B Tabakoff and P L Hoffman
      Molecular Pharmacology June 1992, 41 (6) 1142-1148;

  3. Reynolds, I J

    1. 1,5-(Diethylamino)piperidine, a novel spermidine analogue that more specifically activates the N-methyl-D-aspartate receptor-associated polyamine site.
      I J Reynolds
      Molecular Pharmacology June 1992, 41 (6) 989-992;

  4. Roques, B P

    1. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
      C Durieux, M Ruiz-Gayo, P J Corringer, F Bergeron, B Ducos and B P Roques
      Molecular Pharmacology June 1992, 41 (6) 1089-1095;

  5. Ruiz-Gayo, M

    1. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
      C Durieux, M Ruiz-Gayo, P J Corringer, F Bergeron, B Ducos and B P Roques
      Molecular Pharmacology June 1992, 41 (6) 1089-1095;

S

  1. Sadowski, S

    1. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
      M A Cascieri, R R Huang, T M Fong, A H Cheung, S Sadowski, E Ber and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1096-1099;

  2. Savier, E

    1. Stimulation of monooxygenation and conjugation after liver transplantation in the rat: involvement of Kupffer cells.
      W Qu, E Savier and R G Thurman
      Molecular Pharmacology June 1992, 41 (6) 1149-1154;

  3. Schmidt, H H

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

  4. Schwartz, R D

    1. Functionally relevant gamma-aminobutyric acidA receptors: equivalence between receptor affinity (Kd) and potency (EC50)?
      P P Edgar and R D Schwartz
      Molecular Pharmacology June 1992, 41 (6) 1124-1129;

  5. Shoemaker, J E

    1. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
      C F Bennett, M Y Chiang, H Chan, J E Shoemaker and C K Mirabelli
      Molecular Pharmacology June 1992, 41 (6) 1023-1033;

  6. Strader, C D

    1. Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange.
      D L Barber, M B Ganz, P B Bongiorno and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1056-1060;
    2. Involvement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the beta-adrenergic receptor in the activation of Gs.
      A H Cheung, R R Huang and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1061-1065;
    3. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
      M A Cascieri, R R Huang, T M Fong, A H Cheung, S Sadowski, E Ber and C D Strader
      Molecular Pharmacology June 1992, 41 (6) 1096-1099;

  7. Swartz, K J

    1. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
      K J Swartz, W J Koroshetz, A H Rees and J E Huettner
      Molecular Pharmacology June 1992, 41 (6) 1130-1141;

T

  1. Tabakoff, B

    1. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function.
      K R Iorio, L Reinlib, B Tabakoff and P L Hoffman
      Molecular Pharmacology June 1992, 41 (6) 1142-1148;

  2. Tajima, K

    1. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
      S Wakusawa, S Nakamura, K Tajima, K Miyamoto, M Hagiwara and H Hidaka
      Molecular Pharmacology June 1992, 41 (6) 1034-1038;

  3. Thurman, R G

    1. Stimulation of monooxygenation and conjugation after liver transplantation in the rat: involvement of Kupffer cells.
      W Qu, E Savier and R G Thurman
      Molecular Pharmacology June 1992, 41 (6) 1149-1154;

V

  1. Van Meel, J C

    1. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
      W Wienen, A B Mauz, J C Van Meel and M Entzeroth
      Molecular Pharmacology June 1992, 41 (6) 1081-1088;

  2. Varrault, A

    1. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
      A Varrault, L Journot, Y Audigier and J Bockaert
      Molecular Pharmacology June 1992, 41 (6) 999-1007;

W

  1. Wakusawa, S

    1. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
      S Wakusawa, S Nakamura, K Tajima, K Miyamoto, M Hagiwara and H Hidaka
      Molecular Pharmacology June 1992, 41 (6) 1034-1038;

  2. Waldman, S A

    1. Identification of two affinity states of low affinity receptors for Escherichia coli heat-stable enterotoxin: correlation of occupation of lower affinity state with guanylate cyclase activation.
      M R Crane, M Hugues, P D O'Hanley and S A Waldman
      Molecular Pharmacology June 1992, 41 (6) 1073-1080;

  3. Warner, T D

    1. Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages.
      J A Mitchell, K L Kohlhaas, T Matsumoto, J S Pollock, U Förstermann, T D Warner, H H Schmidt and F Murad
      Molecular Pharmacology June 1992, 41 (6) 1163-1168;

  4. Weir, A

    1. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization.
      L H Overby, S Nishio, A Weir, G T Carver, C G Plopper and R M Philpot
      Molecular Pharmacology June 1992, 41 (6) 1039-1046;

  5. Whiting, P

    1. Activation of protein kinase C selectively inhibits the gamma-aminobutyric acidA receptor: role of desensitization.
      N J Leidenheimer, S J McQuilkin, L D Hahner, P Whiting and R A Harris
      Molecular Pharmacology June 1992, 41 (6) 1116-1123;

  6. Wienen, W

    1. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
      W Wienen, A B Mauz, J C Van Meel and M Entzeroth
      Molecular Pharmacology June 1992, 41 (6) 1081-1088;

  7. Woodward, R M

    1. Effects of hexachlorocyclohexanes on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by RNA from mammalian brain and retina.
      R M Woodward, L Polenzani and R Miledi
      Molecular Pharmacology June 1992, 41 (6) 1107-1115;

  8. Wu, Y

    1. Helicase inhibition by anthracycline anticancer agents.
      N R Bachur, F Yu, R Johnson, R Hickey, Y Wu and L Malkas
      Molecular Pharmacology June 1992, 41 (6) 993-998;

Y

  1. Yocca, F D

    1. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
      F D Yocca, L Iben and E Meller
      Molecular Pharmacology June 1992, 41 (6) 1066-1072;

  2. Yu, F

    1. Helicase inhibition by anthracycline anticancer agents.
      N R Bachur, F Yu, R Johnson, R Hickey, Y Wu and L Malkas
      Molecular Pharmacology June 1992, 41 (6) 993-998;

Z

  1. Zheng, B

    1. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
      T C Chambers, B Zheng and J F Kuo
      Molecular Pharmacology June 1992, 41 (6) 1008-1015;
Back to top

In this issue